Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.
Also called NCT07527650
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 180 participants
- Registry
-
NCT07527650
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07527650. Randomized; triple masking; primary purpose treatment. Start 2026-05-18 (actual); primary completion 2027-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Condition
- T2DM
- Intervention (Drug)
- HM15275
- Intervention (Drug)
- Placebo of HM15275
- Lead sponsor
- Hanmi Pharmaceutical Company Limited
Record details
- Record id
cardio:ct-nct07527650- Content hash
4723fb38e053b0aedc9a70fd662be09e8c7fbc0fa05253af1fcfd0c984d7df6e